185Followers on Owler

Sprim Als Investments

Sprim Als has invested in 5 companies and its latest investment was AUM Biosciences on Oct 11, 2021

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

AUM is an oncology-focused biotechnology company that develops medicines for the treatment of cancer.
$27M
Oct 11, 2021
-
OBVIOHEALTH is a provider of mobile-based clinical trail services.
$31M
Jun 30, 2021
-
vWise develops an employee benefits platform that offers retirement plan enrollment and analytics solutions for advisors.
$8.6M
Jun 06, 2021
-
Travecta is a New York-based biotechnology firm that develops and commercializes novel therapies for the treatment of central nervous system disorders.
$15M
May 11, 2020
-
Travecta is a New York-based biotechnology firm that develops and commercializes novel therapies for the treatment of central nervous system disorders.
-
Sep 05, 2017
-

Frequently Asked Questions about Sprim Als

  1. What is Sprim Als investing in?

    Sprim Als has invested in 5 companies including AUM Biosciences, ObvioHealth and Vwise, Inc.
  2. What company did Sprim Als invest in?

    Sprim Als invested in a total 5 companies including AUM Biosciences, ObvioHealth and Vwise, Inc.
  1. What are the top 5 investments by Sprim Als?

    The top companies in which Sprim Als invested are AUM Biosciences, ObvioHealth, Vwise, Inc., Travecta and Travecta